Boston Scientific Corp
Research Boston Scientific Corp (BSX) on Bullrun: market cap USD 72.13B, P/E 20.2. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBSX
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 72.13B
- P/E20.2
- Financial periodQ2 2026
- RevenueUSD 5.44B
- Net incomeUSD 907.00M
- Free cash flow-USD 451.00M
- Gross margin70.7%
Valuation Snapshot
latest market cap is USD 72.13B; P/E is 20.2.
Peer valuation comparison
Latest P/E is 20.22x versus a Healthcare sector median of 24.46x (17.3% below).
Latest P/E is 20.22x versus a United States median of 24.87x (18.7% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 20.07B | USD 2.89B | USD 3.66B | 69.0% | 1.94 | USD 1.97B | USD 299.00M | USD 24.23B |
| FY2024 | USD 16.75B | USD 1.85B | USD 2.65B | 68.6% | 1.25 | USD 414.00M | USD 1.78B | USD 21.77B |
| FY2023 | USD 14.24B | USD 1.59B | USD 1.79B | 69.5% | 1.07 | USD 865.00M | USD 531.00M | USD 19.28B |
| FY2022 | USD 12.68B | USD 698.00M | USD 938.00M | 68.8% | 0.45 | USD 928.00M | USD 20.00M | USD 17.57B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 72.13B | 20.2 | n/a | n/a |
| 2025 | 2025-12-31 | USD 141.40B | 49.1 | n/a | n/a |
| 2024 | 2024-12-31 | USD 131.71B | 71.5 | n/a | n/a |
| 2023 | 2023-12-29 | USD 84.69B | 70.5 | n/a | n/a |
| 2022 | 2022-12-30 | USD 66.27B | 110.2 | n/a | n/a |
| 2021 | 2021-12-31 | USD 60.56B | 61.6 | n/a | n/a |
About Boston Scientific Corp
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Boston Scientific Corp's market cap?
Boston Scientific Corp's market capitalization is USD 72.13B.
What is Boston Scientific Corp's P/E ratio?
Boston Scientific Corp's price-to-earnings (P/E) ratio is 20.2.
What does Boston Scientific Corp do?
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.